Volume 9, Issue 4 (2021)                   Health Educ Health Promot 2021, 9(4): 419-425 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Zarini E, Fallahi A, Bahmani A, Rahmani A. Psychometrics of a Scale on the Fatty Liver Disease-Related Health Beliefs in Middle-Aged Iranians. Health Educ Health Promot 2021; 9 (4) :419-425
URL: http://hehp.modares.ac.ir/article-5-52999-en.html
1- Student Research Committee, Kurdistan University of Medical Sciences, Sanandaj, Iran
2- Social Determinants of Health Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran , arezofalahi91@gmail.com
3- Department of Public Health, Faculty of Health, Kurdistan University of Medical Sciences, Sanandaj, Iran
4- Nursing and Midwifery Care Research Center, School of Nursing and Midwifery, Tehran University of Medical Sciences, Tehran, Iran
Abstract:   (878 Views)

Aims: The growing prevalence of fatty liver is a major threat to health. This study aimed to design and measure a psychometric scale on the fatty liver disease-related health beliefs in middle-aged Iranian people.
Instrument & Methods: This qualitative descriptive study was performed on middle-aged people referring to the Comprehensive Health Service Centers of Qorveh, Kurdistan Province, Iran, in 2020. An extensive literature review was performed, and interviews were done with people with fatty liver disease and experts in the field. The interviews were analyzed through a directed content analysis approach. The researchers applied an existing theory (health belief model) and designed and compiled 90 items.
Findings: Following evaluation of the face and content validity and obtaining item impact mora than 1.5, CVI more than 0.62, and validity mora than 0.79, a research scale with 57 items was designed. After exploratory factor analysis, 49 items with factor loading mora than 0.5 were confirmed, covering seven factors with a predictive power of 57.5. The reliability of perceived susceptibility, perceived severity, perceived benefits, perceived barriers, cue to internal action, cue to external action, and self-efficacy were 0.90, 0.89, 0.85, 0.81, 0.91, 0.86, and 0.88, respectively. The total reliability of the scale was also confirmed (Cronbach's alpha=0.92).
Conclusion: The designed scale has appropriate validity and reliability for measuring the health belief constructs associated with fatty liver in middle-aged people.
 

Full-Text [PDF 631 kb]   (899 Downloads) |   |   Full-Text (HTML)  (414 Views)  
Article Type: Descriptive & Survey | Subject: Health Communication
Received: 2021/05/23 | Accepted: 2021/08/12 | Published: 2021/12/7
* Corresponding Author Address: Determinants of Health Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran

References
1. Jamali R, Jamali A. Nonalcoholic fatty liver disease. FEYZ. 2010;14(2):169-79. [Persian] [Link]
2. Kwak MS, Kim D. Nonalcoholic fatty liver disease and lifestyle modifications, focusing on physical activity. Korean J Intern Med. 2018;33(1):64-74. [Link] [DOI:10.3904/kjim.2017.343] [PMID] [PMCID]
3. Vernon G, Baranova A, Younossi Z. Systematic review: The epidemiology and natural history of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 2011;34(3):274-85. [Link] [DOI:10.1111/j.1365-2036.2011.04724.x] [PMID]
4. Perdomo CM, Fruhbeck G, Escalada J. Impact of nutritional changes on nonalcoholic fatty liver disease. Nutrients. 2019;11(3):677. [Link] [DOI:10.3390/nu11030677] [PMID] [PMCID]
5. Ghaemi A, Taleban F, Hekmatdoost A, Rafiei A, Hosseini V, Amiri Z, et al. Effect of weight reduction diet on nonalcoholic fatty liver disease. Iran J Nutr Sci Food Technol. 2013;8(2):123-34. [Persian] [Link]
6. Kalvandi R, Rajabi M, Kahramfar Z, Chaleh Cheleh T. Investigation of the effect of artichoke (Cynara Scolymus L.) on characteristics of the fatty liver. Complement Med J Facu Nurs Midwifery. 2020;10(2):134-47. [Persian] [Link] [DOI:10.32598/cmja.10.2.891.1]
7. Schattenberg JM, Ekstedt M. Assessing the disease burden of nonalcoholic fatty liver disease in the real world-big data and big numbers. BMC Med. 2019;17(1):123. [Link] [DOI:10.1186/s12916-019-1357-y] [PMID] [PMCID]
8. Cai J, Zhang XJ, Li H. Progress and challenges in the prevention and control of nonalcoholic fatty liver disease. Med Res Rev. 2019;39(1):328-48. [Link] [DOI:10.1002/med.21515] [PMID]
9. Alswat K, Aljumah AA, Sanai FM, Abaalkhail F, Alghamdi M, Al Hamoudi WK, et al. Nonalcoholic fatty liver disease burden-Saudi Arabia and United Arab Emirates, 2017-2030. Saudi J Gastroenterol. 2018;24(4):211-9. [Link] [DOI:10.4103/sjg.SJG_122_18] [PMID] [PMCID]
10. Tapper EB, Lai M. Weight loss results in significant improvements in quality of life for patients with nonalcoholic fatty liver disease: A prospective cohort study. Hepatology. 2016;63(4):1184-9. [Link] [DOI:10.1002/hep.28416] [PMID] [PMCID]
11. Alam S, Fahim SM, Chowdhury MAB, Hassan MZ, Azam G, Mustafa G, et al. Prevalence and risk factors of nonalcoholic fatty liver disease in Bangladesh. JGH Open. 2018;2(2):39-46. [Link] [DOI:10.1002/jgh3.12044] [PMID] [PMCID]
12. Shi L, Liu ZW, Li Y, Gong C, Zhang H, Song LJ, et al. The prevalence of nonalcoholic fatty liver disease and its association with lifestyle/dietary habits among university faculty and staff in Chengdu. Biomed Environ Sci. 2012;25(4):383-91. [Link]
13. Bellentani S, Scaglioni F, Marino M, Bedogni G. Epidemiology of nonalcoholic fatty liver disease. Dig Dis. 2010;28(1):155-61. [Link] [DOI:10.1159/000282080] [PMID]
14. Keating SE, Adams LA. Exercise in NAFLD: Just do it. J Hepatol. 2016;65(4):671-3. [Link] [DOI:10.1016/j.jhep.2016.06.022] [PMID]
15. Lu FB, Zheng KI, Rios RS, Targher G, Byrne CD, Zheng MH. Global epidemiology of lean nonalcoholic fatty liver disease: A systematic review and meta‐analysis. J Gastroenterol Hepatol. 2020;35(12):2041-50. [Link] [DOI:10.1111/jgh.15156] [PMID]
16. Della Pepa G, Vetrani C, Lombardi G, Bozzetto L, Annuzzi G, Rivellese AA. Isocaloric dietary changes and nonalcoholic fatty liver disease in high cardiometabolic risk individuals. Nutrients. 2017;9(10):1065. [Link] [DOI:10.3390/nu9101065] [PMID] [PMCID]
17. Mlynarsky L, Schlesinger D, Lotan R, Webb M, Halpern Z, Santo E, et al. Nonalcoholic fatty liver disease is not associated with a lower health perception. World J Gastroenterol. 2016;22(17):4362-72. [Link] [DOI:10.3748/wjg.v22.i17.4362] [PMID] [PMCID]
18. Mahady SE, Adams LA. Burden of nonalcoholic fatty liver disease in Australia. J Gastroenterol Hepatol. 2018;33 Suppl 1:1-11. [Link] [DOI:10.1111/jgh.14270] [PMID]
19. Sohrabpour AA, Rezvan H, Amini-Kafiabad S, Dayhim MR, Merat S, Pourshams A. Prevalence of nonalcoholic steatohepatitis in Iran: A population based study. Middle East J Dig Dis. 2010;2(1):14-19. [Persian] [Link]
20. Parkash O, Hamid S. Are we ready for a new epidemic of under recognized liver disease in south Asia especially in Pakistan? nonalcoholic fatty liver disease. J Pak Med Assoc. 2013;63(1):95-9. [Link]
21. Akbari M, Zohari-Anboohi S. Comparison of the nutrition of patients with and without nonalcoholic fatty liver in Tehran. Intern Med Med Investig J. 2018;3(4):18-22. [Link] [DOI:10.24200/imminv.v3i4.170]
22. Hallsworth K, Fattakhova G, Hollingsworth KG, Thoma C, Moore S, Taylor R, et al. Resistance exercise reduces liver fat and its mediators in nonalcoholic fatty liver disease independent of weight loss. Gut. 2011;60(9):1278-83. [Link] [DOI:10.1136/gut.2011.242073] [PMID] [PMCID]
23. Hallsworth K, Dombrowski SU, McPherson S, Anstee QM, Avery L. Using the theoretical domains framework to identify barriers and enabling factors to implementation of guidance for the diagnosis and management of nonalcoholic fatty liver disease: A qualitative study. Transl Behav Med. 2020;10(4):1016-30. [Link] [DOI:10.1093/tbm/ibz080] [PMID] [PMCID]
24. Zelber-Sagi S, Bord S, Dror-Lavi G, Smith ML, Towne Jr SD, Buch A, et al. role of illness perception and self-efficacy in lifestyle modification among nonalcoholic fatty liver disease patients. World J Gastroenterol. 2017;23(10):1881-90. [Link] [DOI:10.3748/wjg.v23.i10.1881] [PMID] [PMCID]
25. Glanz K, Rimer BK, Viswanath K. Health behavior and health education: Theory, research, and practice. San Francisco: Jossey-Bass; 2008. [Link]
26. Chawla KS, Talwalkar JA, Keach JC, Malinchoc M, Lindor KD, Jorgensen R. Reliability and validity of the Chronic Liver Disease Questionnaire (CLDQ) in adults with nonalcoholic steatohepatitis (NASH). BMJ Open Gastroenterol. 2016;3(1):000069. [Link] [DOI:10.1136/bmjgast-2015-000069] [PMID] [PMCID]
27. Ghevariya V, Sandar N, Patel K, Ghevariya N, Shah R, Aron J, et al. Knowing what's out there: Awareness of nonalcoholic fatty liver disease. Front Med. 2014;1:4. [Link] [DOI:10.3389/fmed.2014.00004] [PMID] [PMCID]
28. Kline RB. Principles and practice of structural equation modeling. Unknown city: Guilford publications; 2015. [Link]
29. Vakili MM, Jahangiri N. Content validity and reliability of the measurement tools in educational, behavioral, and health sciences research. J Med Educ Dev. 2018;10(28):106-18. [Persian] [Link] [DOI:10.29252/edcj.10.28.106]
30. Beavers AS, Lounsbury JW, Richards JK, Huck SW, Skolits GJ, Esquivel SL. Practical considerations for using exploratory factor analysis in educational research. Pract Assess Res Eval. 2013;18(1):6. [Link]
31. Haghdoost AA, Pourkhandani A, Motaghipisheh S, Farhoudi B, Fahimifar N, Sadeghirad B. Knowledge and attitude concerning HIV/AIDS among Iranian population: A systematic review and meta-analysis. Iran J Epidemiol. 2011;6(4):8-20. [Persian] [Link]
32. Khani Jeihooni A, Kaveh MH, Hajizadeh E, Askari A, Naghizadeh MM. Designing the validity and reliability of osteoporosis prevention instrument based on health belief model in women. J Ilam Univ Med Sci. 2013;22(3):127-36. [Persian] [Link]
33. Fallahi H, Tavafian SS, Yaghmaie F, Hajizadeh E. Developing and Measuring Psychometric Properties of reproductive health behavior in people living with HIV based on health belief model. Hakim Res J. 2013;16(2):118-27. [Persian] [Link]
34. Naderimagham S, Niknami S, Abolhassani F, Hajizadeh E. Development and psychometric properties of perceived self-efficacy scale (SES) for self-care in middle-aged patients with diabetes mellitus type 2. PAYESH. 2013;12(6):679-90. [Persian] [Link] [DOI:10.1186/1471-2458-12-1035] [PMID] [PMCID]
35. Anagnostopoulos F, Dimitrakaki C, Niakas D, Tountas Y. Validity and reliability assessment of health belief scales for mammography screening in Greek asymptomatic women. Psychooncology. 2013;22(8):1912-7. [Link] [DOI:10.1002/pon.3212] [PMID]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.